New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cytek Biosciences, Inc.
CTKB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

891M

Medical - Devices

6.92USD
Shape0.39 ( 5.97%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-10%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated December 3, 2024
1W 6.46 % 1M 33.08 % 3M 32.31 % 1Y -5.98 %

Key Metrics

Shape
  • Market Cap

    891.37M


  • Shares Outstanding

    128.81M


  • Share in Float

    117.03M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    6.92


  • Average Volume

    701152


  • Beta

    1.321


  • Range

    4.66-9.87


  • Industry

    Medical - Devices


  • Website

    https://cytekbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.43x

P/S Ratio

2.35x

P/B Ratio

0.0

Debt/Equity

-5.0%

Net Margin

$-0.1

EPS

How CTKB compares to sector?

P/E Ratio

Relative Strength

Shape

CTKB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$230M

Shape346%

2025-Revenue

$0.21

Shape2851%

2025-EPS

$272K

Shape-91%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2023-12-14

Now: Positive

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+40%

0.07
vs 0.05

Q1.23

arrow
arrow

N/A

-0.03
vs 0.01

Q2.23

arrow
arrow

-67%

0.01
vs 0.03

Q3.23

arrow
arrow

-75%

0.01
vs 0.04

Q4.23

arrow
arrow

N/A

0.07
vs 0.07

Q1.24

arrow
arrow

N/A

-0.05
vs -0.03

Q2.24

arrow
arrow

N/A

-0.08
vs 0.01

Q3.24

arrow
arrow

N/A

0.01
vs 0.01

Q4.24

arrow
arrow

+62%

0.11
vs 0.07

Q1.25

arrow
arrow

+153%

0.03
vs -0.05

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+24%

48.3M  vs 38.9M

Q1.23

arrow
arrow

+6%

37.1M  vs 35.1M

Q2.23

arrow
arrow

+24%

49.7M  vs 40.2M

Q3.23

arrow
arrow

+19%

48M  vs 40.5M

Q4.23

arrow
arrow

+20%

58.2M  vs 48.3M

Q1.24

arrow
arrow

+21%

44.9M  vs 37.1M

Q2.24

arrow
arrow

-6%

46.6M  vs 49.7M

Q3.24

arrow
arrow

+7%

51.5M  vs 48M

Q4.24

arrow
arrow

+6%

61.5M  vs 58.2M

Q1.25

arrow
arrow

+10%

49.1M  vs 44.9M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1%

0.01
vs 0

Q1.23

arrow
arrow

-2%

-0.02
vs 0.01

Q2.23

arrow
arrow

-1%

-0.01
vs -0.02

Q3.23

arrow
arrow

-2%

-0.02
vs -0.01

Q4.23

arrow
arrow

+1%

0.01
vs -0.02

Q1.24

arrow
arrow

-2%

-0.02
vs 0.01

Q2.24

arrow
arrow

-3%

-0.03
vs -0.02

Q3.24

arrow
arrow

+0%

0
vs -0.03

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

105

105
vs 87

21%

Q1.23

arrow
arrow

103

103
vs 105

-2%

Q2.23

arrow
arrow

104

104
vs 103

1%

Q3.23

arrow
arrow

108

108
vs 104

4%

Q4.23

arrow
arrow

102

102
vs 108

-6%

Q1.24

arrow
arrow

122

122
vs 102

20%

Q2.24

arrow
arrow

128

128
vs 122

5%

Q3.24

arrow
arrow

135

135
vs 128

5%

Earnings Growth

Latest News